The GLP-1 Bridge is a temporary federal program, running from July 1, 2026 through December 31, 2027 , that expands access for weight management specifically
Glucagon-like peptide-1 (GLP-1) receptor agonistsincluding semaglutide (Ozempic, Wegovy), liraglutide (Saxenda, Victoza), and tirzepatide (Mounjaro)are highly effective for glycaemic control and weight reduction, but some individuals experience hair thinning during treatment
Compounded semaglutide generally costs around $200 to $300 per month
mass: 21.56 mg Result Date July 9, 2026 Date added July 9, 2026 You may also like Telmisartan Tablets $50.00 CAD Avg
Most of the patients decided for semaglutide for its weekly administration and higher efficacy in achieving weight loss compared to liraglutide [16]
Keep the rest in lyophilized form in the freezer or refrigerator